Drug intelligence / Profile preview

salophen iron chelate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Salophen iron chelate is a synthetic coordination compound consisting of an iron ion complexed with the tetradentate Schiff base ligand salophen (N,N′-bis(salicylidene)-1,2-phenylenediamine). It is classified as a small molecule and has been investigated primarily as an experimental agent. Salophen iron chelate acts as a metal-chelating agent and has potential therapeutic applications in treating conditions related to iron overload and possibly cancer. Its mechanism involves binding to free or excess iron ions in biological systems through strong coordination bonds formed by the ligand's nitrogen and oxygen donor atoms. This sequestration of free iron may reduce oxidative stress or modulate cellular processes dependent on available metal ions. The compound is not approved for clinical use but remains of interest for research into novel chelation therapies and anti-cancer strategies[1][4][7].

Other names
2,2'-[1,2-phenylenebis(nitrilomethylidene)]bis[phenolato]](2-)-N,N',O,O']-iron[2,2'-{benzene-1,2-diylbis[(nitrilo-kappaN)methylylidene]}diphenolato(2-)-kappaO]iron(2+)Q27467790Q-27467790Q 27467790

Beyond the preview

Go deeper on salophen iron chelate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salophen iron chelate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call